|
Powered by Cell Signaling Technology |
| Site Information |
|---|
| NMMDILTtPSMAkPR SwissProt Entrez-Gene |
| Blast this site against: NCBI SwissProt PDB |
| Site Group ID: 3209097 |
| In vivo Characterization | |
|---|---|
| Methods used to characterize site in vivo: | |
| Disease tissue studied: | |
| Relevant cell line - cell type - tissue: | |
| Upstream Regulation | |
|---|---|
| Regulatory protein: | |
| Putative in vivo kinases: | |
| Kinases, in vitro: | |
| Putative upstream phosphatases: | |
| Treatments: | |
| Downstream Regulation | |
|---|---|
| Effects of modification on MASTL: | |
| Effects of modification on biological processes: | |
| References | |
|---|---|
|
Hégarat N, et al. (2014) PP2A/B55 and Fcp1 regulate Greatwall and Ensa dephosphorylation during mitotic exit. PLoS Genet 10, e1004004
24391510 Curated Info |
|
|
Olsen JV, et al. (2010) Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal 3, ra3
20068231 Curated Info |
|
|
Chen RQ, et al. (2009) CDC25B mediates rapamycin-induced oncogenic responses in cancer cells. Cancer Res 69, 2663-8
19276368 Curated Info |
|
|
Dephoure N, et al. (2008) A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A 105, 10762-7
18669648 Curated Info |